Announcing the First Pancanadian Strategic Forum on Cell and Gene Therapy, March 9-10, 2017, Montrea
We are pleased to share the announcement and encourage all CNTRP members to attend the First Pancanadian Strategic Forum on Cell and Gene Therapy, which will take place on March 9 and 10, 2017, at the Westin Montreal.
Organized by CellCAN, in partnership with the Centre for Commercialization of Cancer Immunotherapy (C3i) and BioCanRx, this forum represents a great opportunity to identify concrete actions-from research to commercialization-that can be taken to help stakeholders in our field become better equipped to develop the therapies of the future.
Bringing together a number of national and international experts such as Catherine Bollard, Chris Mason, Jerome Ritz, Adrian Gee and Isabelle Rivière, this forum will:
Highlight the most recent innovations in cell therapy, including cancer immunotherapies.
Reveal facilitators and barriers to cell and gene therapy translation in Canada.
Identify lessons learned and the promising technologies in manufacturing.
Build on effective commercialization strategies for the benefit of all Canadians.
Highlight paths to financing and reimbursement.
Discuss issues related to cell and gene therapy regulation.
To learn more and register for this forum, please visit www.cellcan.com/forum2017 or contact the management team at firstname.lastname@example.org. Early-bird registration deadline is December 31, 2016 at 11:59 PM PDT.